All stories

1 outlets · filed 6 November 2026

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

This story is from the archive. It was covered between 6 November 2026 and 6 November 2026, and nothing below has been updated since. See what is happening now.

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

How it broke

CNBC
1outlets
0videos
1articles